NYSE:PBH - Prestige Consumer Healthcare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$34.15 -1.83 (-5.09 %)
(As of 12/10/2018 04:00 PM ET)
Previous Close$35.98
Today's Range$33.97 - $36.26
52-Week Range$27.84 - $47.29
Volume356,633 shs
Average Volume688,395 shs
Market Capitalization$1.86 billion
P/E Ratio13.24
Dividend YieldN/A
Beta1.01
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. The company's OTC healthcare products include BC/Goody's analgesic powders, Beano for gas prevention, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergy/redness relief, Compound W for wart removal, Debrox for ear wax removal, DenTek PEG oral care, Dramamine for motion sickness relief, and Efferdent denture cleanser tablets. Its OTC healthcare products portfolio also comprises Fess nasal saline spray, Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Hydralyte for oral rehydration, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Pedia-Lax pediatric laxatives, Summer's Eve for feminine hygiene, Little Remedies pediatric OTC products, and The Doctor's NightGuard dental protectors. In addition, the company offers household cleaning products, such as abrasive tub and tile cleaners under the Comet name, as well as Chore Boy, and Spic and Span names. It serves mass merchandisers; and drug, food, dollar, convenience, and club stores. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Receive PBH News and Ratings via Email

Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Pharmaceutical preparations
Sub-IndustryPersonal Products
SectorConsumer Discretionary
Current SymbolNYSE:PBH
Previous Symbol
CUSIP74112D10
Phone914-524-6800

Debt

Debt-to-Equity Ratio1.59
Current Ratio2.15
Quick Ratio1.38

Price-To-Earnings

Trailing P/E Ratio13.24
Forward P/E Ratio11.86
P/E Growth1.78

Sales & Book Value

Annual Sales$1.04 billion
Price / Sales1.70
Cash Flow$3.1946 per share
Price / Cash Flow10.69
Book Value$22.22 per share
Price / Book1.54

Profitability

EPS (Most Recent Fiscal Year)$2.58
Net Income$339.57 million
Net Margins33.38%
Return on Equity11.82%
Return on Assets3.71%

Miscellaneous

Employees530
Outstanding Shares51,740,000
Market Cap$1.86 billion
OptionableOptionable

Prestige Consumer Healthcare (NYSE:PBH) Frequently Asked Questions

What is Prestige Consumer Healthcare's stock symbol?

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

How were Prestige Consumer Healthcare's earnings last quarter?

Prestige Consumer Healthcare Inc (NYSE:PBH) announced its earnings results on Thursday, November, 1st. The company reported $0.65 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.63 by $0.02. The business earned $239.36 million during the quarter, compared to analysts' expectations of $236.28 million. Prestige Consumer Healthcare had a net margin of 33.38% and a return on equity of 11.82%. The firm's revenue was down 7.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.61 earnings per share. View Prestige Consumer Healthcare's Earnings History.

When is Prestige Consumer Healthcare's next earnings date?

Prestige Consumer Healthcare is scheduled to release their next quarterly earnings announcement on Thursday, February 7th 2019. View Earnings Estimates for Prestige Consumer Healthcare.

What guidance has Prestige Consumer Healthcare issued on next quarter's earnings?

Prestige Consumer Healthcare updated its FY19 earnings guidance on Thursday, November, 1st. The company provided EPS guidance of $2.84-2.92 for the period, compared to the Thomson Reuters consensus estimate of $2.86. The company issued revenue guidance of $985-995 million, compared to the consensus revenue estimate of $986.48 million.

What price target have analysts set for PBH?

3 analysts have issued twelve-month price objectives for Prestige Consumer Healthcare's shares. Their predictions range from $38.00 to $43.00. On average, they anticipate Prestige Consumer Healthcare's share price to reach $39.6667 in the next twelve months. This suggests a possible upside of 16.2% from the stock's current price. View Analyst Price Targets for Prestige Consumer Healthcare.

What is the consensus analysts' recommendation for Prestige Consumer Healthcare?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Prestige Consumer Healthcare.

Has Prestige Consumer Healthcare been receiving favorable news coverage?

Media stories about PBH stock have been trending very positive this week, InfoTrie reports. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Prestige Consumer Healthcare earned a news sentiment score of 3.9 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future.

Who are some of Prestige Consumer Healthcare's key competitors?

Who are Prestige Consumer Healthcare's key executives?

Prestige Consumer Healthcare's management team includes the folowing people:
  • Mr. Ronald M. Lombardi, Chairman, Pres & CEO (Age 54)
  • Ms. Christine Sacco, Chief Financial Officer (Age 42)
  • Mr. William C. P'Pool, Sr. VP, Gen. Counsel & Corp. Sec. (Age 53)
  • Mr. Timothy J. Connors, Exec. VP of Sales & Marketing (Age 51)
  • Mr. Jeff Zerillo, Sr. VP of Operations

Who are Prestige Consumer Healthcare's major shareholders?

Prestige Consumer Healthcare's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (12.00%), FMR LLC (11.30%), Vanguard Group Inc. (9.09%), Dimensional Fund Advisors LP (7.02%), JPMorgan Chase & Co. (5.86%) and Wells Fargo & Company MN (4.23%). Company insiders that own Prestige Consumer Healthcare stock include Gary E Costley, Jean A Boyko, Natale S Ricciardi, Ronald M Lombardi, Timothy Connors and William P'pool. View Institutional Ownership Trends for Prestige Consumer Healthcare.

Which institutional investors are selling Prestige Consumer Healthcare stock?

PBH stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., BlackRock Inc., Fisher Asset Management LLC, Dupont Capital Management Corp, Allianz Asset Management GmbH, Fuller & Thaler Asset Management Inc., AQR Capital Management LLC and FMR LLC. Company insiders that have sold Prestige Consumer Healthcare company stock in the last year include Jean A Boyko and Timothy Connors. View Insider Buying and Selling for Prestige Consumer Healthcare.

Which institutional investors are buying Prestige Consumer Healthcare stock?

PBH stock was bought by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Dimensional Fund Advisors LP, Massachusetts Financial Services Co. MA, Macquarie Group Ltd., JPMorgan Chase & Co., Acadian Asset Management LLC, Man Group plc and Rice Hall James & Associates LLC. Company insiders that have bought Prestige Consumer Healthcare stock in the last two years include Gary E Costley, Natale S Ricciardi, Ronald M Lombardi and William P'pool. View Insider Buying and Selling for Prestige Consumer Healthcare.

How do I buy shares of Prestige Consumer Healthcare?

Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Prestige Consumer Healthcare's stock price today?

One share of PBH stock can currently be purchased for approximately $34.15.

How big of a company is Prestige Consumer Healthcare?

Prestige Consumer Healthcare has a market capitalization of $1.86 billion and generates $1.04 billion in revenue each year. The company earns $339.57 million in net income (profit) each year or $2.58 on an earnings per share basis. Prestige Consumer Healthcare employs 530 workers across the globe.

What is Prestige Consumer Healthcare's official website?

The official website for Prestige Consumer Healthcare is http://www.prestigebrands.com.

How can I contact Prestige Consumer Healthcare?

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected]


MarketBeat Community Rating for Prestige Consumer Healthcare (NYSE PBH)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  365 (Vote Outperform)
Underperform Votes:  264 (Vote Underperform)
Total Votes:  629
MarketBeat's community ratings are surveys of what our community members think about Prestige Consumer Healthcare and other stocks. Vote "Outperform" if you believe PBH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2018 by MarketBeat.com Staff

Featured Article: What is a Futures Contract?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel